Qualitative analysis of bodybuilder forums reveals off-label GLP-1 drug use for physique enhancement, with users developing folk pharmacological knowledge about dosing, cycling, and harm reduction strategies outside medical supervision.
Off-label physique use growingBodybuilding communities develop folk pharmacology for GLP-1 drugs—unsupervised dosing and cycling protocols that healthcare providers need to understand for harm reduction
What the researchers found
Off-label GLP-1 use in bodybuilding: semaglutide, tirzepatide. Folk pharmacology: user-developed dosing/cycling protocols. Risk: unsupervised use, experimentation. Harm reduction: community-developed strategies. Online forums: primary information source.
Why it matters
A growing population is using GLP-1 drugs without medical supervision. Understanding their practices enables healthcare providers to engage these users with evidence-based guidance rather than driving them further from medical care.
How the study worked
Qualitative analysis of online bodybuilding forum discussions about GLP-1 drug use for physique enhancement.
What this study cannot tell us
Qualitative study—cannot quantify prevalence. Online forums may not represent all users. Self-reported practices. No outcomes data.
How to read the evidence
Qualitative research. Good for understanding user behaviors and practices.
When this study was published
Published in 2025.
The bigger picture
GLP-1 drug off-label use is extending beyond weight loss into physique-oriented communities. Healthcare providers must engage with these users proactively to prevent harm.
Questions still open
- How prevalent is bodybuilding GLP-1 drug use?
- Are bodybuilder dosing protocols safe?
- Should harm reduction guidelines be developed for off-label GLP-1 users?
Common questions
Are bodybuilders using GLP-1 drugs?
Is off-label GLP-1 use by bodybuilders safe?
Read the original research
Off-label GLP-1 weight-loss medicine use among online bodybuilders: Folk pharmacology, risk and harm reduction.
The International journal on drug policy, 142, 104854
Citation
Turnock, Luke A; Hearne, Evelyn; Germain, Jennifer; Hirst, Mikey; Townshend, Honor D; Lazuras, Lambros. (2025). Off-label GLP-1 weight-loss medicine use among online bodybuilders: Folk pharmacology, risk and harm reduction.. The International journal on drug policy, 142, 104854. https://doi.org/10.1016/j.drugpo.2025.104854